When Symptoms of Covid-19 Don’t Go Away

[Hypocrite-The]

Coronavirus 'long haulers' feared they would never recover. Then they got the vaccine
ABC Health & Wellbeing
/
By Will Ockenden for Coronacast
Posted 10hhours ago, updated 4hhours ago

Mary contracted COVID-19 in March 2020, and suffered from lingering systems for 12 months. (
Supplied: Mary Bempeki
)
Share

When Mary Bempeki contracted COVID-19 in March last year, she thought she would get over the disease and continue on with her life.
Key points:

• Mary Bempeki was still in the grips of coronavirus, one year after contracting it
• Until now, medical science has not been able to offer much in the way of treatment or advice to patients with long COVID
• Ms Bempeki says getting vaccinated improved her health greatly

But two weeks after she was infected, when most COVID-19 patients start to improve, her health took a turn for the worse.
"I started to have neurological symptoms. I had abdominal pain, internal tremors, red and swollen eyes," she said.
She waited for the pain to ease, but 12 months on, Ms Bempeki was seemingly still in the grip of the virus.
She has what is known as "long COVID", a phenomenon experienced by an estimated 30 per cent of people who are infected by coronavirus.
LIVE UPDATES: Read our blog for the latest news on the COVID-19 pandemic.
While the vast majority of patients recover after about 14 days, for those with long COVID, the nightmare never seems to end.
They report fatigue, breathlessness, being incredibly tired and unable to concentrate, long after contracting the virus.
The phenomenon has intrigued medical researchers, who still don't know how long COVID works and why some people suffer from it.
Until now, modern medical science has not been able to offer much in the way of treatment or advice to patients.
But Ms Bempeki believes she may have stumbled on a solution for her symptoms.
Days after she received her COVID-19 vaccine, something strange happened.
"It almost kind of disappeared," she said.

Long COVID patients report that it does not matter which vaccine they receive in order to feel better.(
AP: Jeff J Mitchell
)'I really feel much, much better'
After a year of crippling fatigue, kidney problems, bleeding gums and other strange symptoms, Ms Bempeki woke up one day and felt "99 per cent improved".
Got questions about the COVID vaccines? We have answers

Confused about Australia's vaccine rollout? We've tracked down the answers to the questions you've been asking.
Read more
She'd received the AstraZeneca vaccine several days earlier.

"I was suffering every day with internal tremors, which I still feel now, but it's less intense," she said.

"I will try to start to work a few hours every week to see how it's going. But I really feel much, much better."
Ms Bempeki is not alone. Growing anecdotal reports, along with a new — but yet to be peer-reviewed — study have raised the question: Can the coronavirus vaccine cure long COVID?

In the United States, many so-called long haulers — a term people suffering from long COVID call themselves — say they are feeling better after receiving a vaccine.
It also doesn't seem to matter which vaccine the patient receives. Reports are similar among people who get the Pfizer, Moderna or AstraZeneca shot.
But individual anecdotal reports are not enough on their own to say if the vaccine can cure or reduce long COVID symptoms.
Study gives 'long haulers' hope

Long COVID patients say it is worth getting the vaccine.(
Getty: Vincenzo Izzo/LightRocket
)
A British study, which has not yet been peer-reviewed or published in a journal, has captured the attention of long haulers, desperate for any good news that could help reduce and rid them of their symptoms.
This is what it's like to live with long COVID

Sarah has not been able to work or even cook for herself since having COVID-19 in mid-2020. She is suffering chronic pain, fatigue and PTSD and is calling for more recognition of this emerging condition.
Read more
The study, which followed a small number of people, was set up to track the health outcomes of people hospitalised with COVID-19.
"We noticed that many patients were quite hesitant about receiving vaccines, which sort of surprised us because we thought they'd be desperate to get them," said Fergus Hamilton, one of the study's authors from the University of Bristol.
"We noted that they were very worried. They've been unwell before, they have quite dramatic symptoms, and they felt we were giving them the same thing [with the vaccine]," Dr Hamilton said.
The study found that there is no evidence to suggest that currently available COVID vaccines worsen long COVID symptoms, quality of life or mental wellbeing.
It also uncovered an intriguing possibility. The vaccine might actually help reduce or eliminate symptoms experienced by long COVID patients.
Dr Hamilton is the first to point out the reported results come with many, many caveats, such as a small sample size and lack of peer review. Untangling the placebo effects in these studies is also very difficult.

"If you're an optimist, you think, 'Oh wow, this is a nice, intriguing finding,'" he said.

"If you're a pessimist, you say that sometimes the stats just work out and find the association.
"We certainly weren't looking for it and although we reported the results, I'd like to think that we don't go on about it or certainly make any claims."
Read more about COVID-19 vaccines:

• The 'concerning' divide in Australians' attitudes to vaccines
• Pausing AstraZeneca rollout an "overreaction", experts say
• Tracking Australia's COVID vaccine rollout

'We're still in the early days of understanding long COVID'
Nonetheless, the UK study is the first study with a reported link between receiving a coronavirus vaccine and improved long COVID symptoms.
Dr Vanessa Bryant of the Walter and Eliza Hall Institute of Medical Research agrees that it's interesting, but says it's too soon to make any bold conclusions.
"We're starting to put this together with anecdotal evidence, and there will be larger studies coming in behind," she said.
"We're still in the early days of understanding long COVID."
While it's still too early to say whether or not the vaccine can help with long COVID, there are several hypotheses as to what could be going on.
Health in your Instagram feed

Follow @abchealth on Instagram, where we're busting myths and sharing practical, smart health advice.
Read more
One is the idea of a viral reservoir, where fragments of the virus hang around after the infection and continue to trigger the patient's immune system into constantly trying to fight something off.
"The immune system might be working overtime, unnecessarily, continuing to launch its assault, even though the threat is essentially over," Dr Bryant said.
If that's the case, the vaccine could potentially clean up the reservoir. But it's also possible the vaccine doesn't help at all, and it's just a placebo effect or people recovering naturally.
"I think this question is going to be out there for some time," Dr Hamilton said.
"I don't think there's going to be a huge paper tomorrow that's going to drop, that's going to conclusively answer this either way.
"But it is intriguing, isn't it?"

 

[Hypocrite-The]

People who have had COVID-19 might need only one coronavirus vaccine dose
ABC Health & Wellbeing
/
By health reporter Lauren Roberts
Posted Yesterday at 3:00am

The TGA has approved two vaccines for use in Australia, the AstraZeneca and Pfizer candidates.(
Photo By Victoria Jones/PA Images Via Getty Images
)
Share

People who have previously had COVID-19 may only need one shot of a coronavirus vaccine to be protected, according to new research.
But experts say all Australians — regardless of whether they've been infected or not — should still get two doses.
Key points:

• Two studies suggest people who've previously had coronavirus develop antibodies that help protect them against being reinfected
• Two-dose vaccinations prompt a similar response to people who've previously been infected with COVID-19
• We still don't know how long the protection by antibodies or COVID-19 vaccines will remain effective

The study, published this month by The Journal of the American Medical Association, found people who have already had COVID-19 — even those who didn't show symptoms — had higher antibody responses to a single vaccine dose than those who were not previously infected.
About 4,000 participants were given either the Pfizer vaccine (which is approved for use in Australia) or the Moderna vaccine, both of which use new mRNA technology.
David Gordon, head of microbiology and infectious diseases at Flinders University, said the difference in responses between the two groups was immediate.
"Seven days after the vaccination, people who haven't had COVID essentially have no detectable antibody [responses] at all … and then 14 days after the vaccine, the antibody level starts to go up," Professor Gordon said.
"But if you take the people who were antibody positive at the beginning, who'd had COVID, they have colossal antibody responses within seven days."
LIVE UPDATES: Read our blog for the latest news on the COVID-19 pandemic.Experts say findings 'not surprising'
Larisa Labzin, research fellow at the Institute for Molecular Bioscience at the University of Queensland, said the results weren't surprising.
Your COVID-19 vaccine questions answered

Got questions about the COVID-19 vaccines being used in Australia? We have answers.
Read more
"Essentially, all a vaccine is doing is trying to trick the immune system into thinking that it's seen the virus before," she said.
"If you've already had COVID, your immune system has already encountered the virus and it's kept its arsenal of weapons on file, so it's ready to respond.

The immune system is like, 'Oh, I recognise this, and I'm going to mount an even stronger response.'"

That's also why we have two vaccine shots.
"We know the immune response is stronger upon that second challenge," Dr Labzin said.
We still don't know how long the COVID-19 vaccines will remain effective, and whether or not we'll need a booster shot in future to protect against new variants.
Influenza, for example, needs an annual flu jab because the virus mutates every year.
Professor Gordon said while initial the results of the study were encouraging, it was limited in what it could tell us about immunity because it didn't compare participants after the second dose.
"There's always been a little bit of a question mark about how long the immunity to coronavirus will last, and fundamentally that will depend on whether there is a memory immune response," he said.
"And this study indicates that there is a memory immune response."
Infections 'not a contraindication to vaccination'
Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.
WATCH
Duration: 3 minutes 19 seconds3m 19s

1,000 GP clinics start vaccinations for priority groups
The study suggests, given ongoing worldwide vaccine shortages, there may be merit for a single-dose vaccine regime for people who have had COVID-19.
But the Australian Technical Advisory Group on Immunisation says previous infection with the coronavirus is "not a contraindication to vaccination", meaning there's no additional risk and getting the vaccine is still a good idea.
Dr Labzin backed that recommendation.

"We always like to go with what's been tested and the phase-three clinical trials used two doses, and that's what's shown to have worked," she said.

"There is no evidence that having two doses of the vaccine after having COVID will be dangerous; if anything it's going to be safer, so it's better to err on the side of caution."
Previous infection may protect against reinfection
Further research, also published in the JAMA, appears to show that people who've previously been infected with SARS-CoV-2 (the virus that causes COVID-19) are well protected against being reinfected.
It builds on the same concept behind the previous research; that the immune system remembers the spike protein and mounts a response more quickly than in people who haven't been infected.
Health in your Instagram feed

Follow @abchealth on Instagram, where we're busting myths and sharing practical, smart health advice.
Read more
That kind of finding is exactly what the whole principle on which vaccines are based on, Dr Labzin said.

"Once we've had an infection and our immune system has fought it off, it doesn't forget how to fight that infection off.

"It keeps the details of that on file and also the details of how we fought off the virus in terms of the antibodies."
The body fights off viruses like SARS-CoV-2 by binding antibodies to it, which stops it getting into the cells and infecting the body.
Professor Gordon said participants in the second study appeared to be better protected as time went on.
The study of 3.2 million people found that while the risk of being reinfected was not reduced in the first 30 days, it became more pronounced after 30 days and progressively strengthened through the 90-day observation period and beyond.
"It is consistent with what we would expect from immune responses to many viral infections," Professor Gordon said.
After the body is first exposed to the virus, it takes one or two weeks to develop a good response.
"We know that with COVID, if you get infected today you don't get antibodies today, or the next day; it takes weeks to develop a good immune response," he said.
"But the immune system has a memory capacity, so then when you get exposed to the same virus six months later or in many cases years and years later ... the immune response is very rapid."

 

[Hypocrite-The]

If all infected were given the medication, Hydroxychloroquine ,,,this would be over by now,,,
Rio Giardinieri thought he would not make it through the night and doctors said there was nothing more they could do. But his good friend said what about trying Hydroxychloroquine? He had nothing to lose so the doctors put him on the anti-malaria drug and within 8 hours Rio was not only still alive, but feeling really great.
Good job he did not listen to CNN, or MSNBC isn't it. You see the lying msm hate President Trump so much that they are telling everyone that the malaria drug is dangerous and does not work. It is time to remove CNN, MSNBC and the other liars from our screens.
Well done Rio. So happy for you and your family.

https://www.bitchute.com/video/d5MuPznhhE10/

 

[Hypocrite-The]

They Had Mild Covid. Then Their Serious Symptoms Kicked In.
Pam Belluck
Tue, 23 March 2021, 8:32 pm


In the fall, after Samar Khan came down with a mild case of COVID-19, she expected to recover and return to her previous energetic life in Chicago. After all, she was just 25, and healthy.
But weeks later, she said, “this weird constellation of symptoms began to set in.”
She had blurred vision encircled with strange halos. She had ringing in her ears, and everything began to smell like cigarettes or Lysol. One leg started to tingle, and her hands would tremble while putting on eyeliner.
Sign up for The Morning newsletter from the New York Times
She also developed “really intense brain fog,” she said. Trying to concentrate on a call for her job in financial services, she felt as if she had just come out of anesthesia. And during a debate about politics with her husband, Zayd Hayani, “I didn’t remember what I was trying to say or what my stance was,” she said.
By the end of the year, Khan was referred to a special clinic for COVID-related neurological symptoms at Northwestern Memorial Hospital in Chicago, which has been evaluating and counseling hundreds of people from across the country who are experiencing similar problems.
Now, the clinic, which sees about 60 new patients a month, in-person and via telemedicine, has published the first study focused on long-term neurological symptoms in people who were never physically sick enough from COVID-19 to need hospitalization, including Khan.
The study of 100 patients from 21 states, published Tuesday in The Annals of Clinical and Translational Neurology, found that 85% of them experienced four or more neurological issues like brain fog, headaches, tingling, muscle pain and dizziness.
“We are seeing people who are really highly, highly functional individuals, used to multitasking all the time and being on top of their game, but, all of a sudden, it’s really a struggle for them,” said Dr. Igor J. Koralnik, the chief of neuro-infectious diseases and global neurology at Northwestern Medicine, who oversees the clinic and is the senior author of the study.
The report, in which the average patient age was 43, underscores the emerging understanding that for many people, long COVID can be worse than their initial bouts with the infection, with a stubborn and complex array of symptoms.
This month, a study that analyzed electronic medical records in California found that nearly a third of the people struggling with long COVID symptoms — like shortness of breath, cough and abdominal pain — did not have any signs of illness in the first 10 days after they tested positive for the coronavirus. Surveys by patient-led groups have also found that many COVID survivors with long-term symptoms were never hospitalized for the disease.
In the Northwestern study, many experienced symptoms that fluctuated or persisted for months. Most improved over time, but there was wide variation.
“Some people after two months are 95% recovered, while some people after nine months are only 10% recovered,” Koralnik said. Five months after contracting the virus, patients estimated, they felt on average only 64% recovered.
Across the country, doctors who are treating people with post-COVID neurological symptoms say the study’s findings echo what they have been seeing.
“We need to take this seriously,” said Dr. Kathleen Bell, chairwoman of the physical medicine and rehabilitation department at the University Texas Southwestern Medical Center, who was not involved in the new study. “We can either let people get worse and the situation gets more complicated, or we can really realize that we have a crisis.”
Bell and Koralnik said many of the symptoms resembled those of people who had concussions or traumatic brain injuries or who had mental fogginess after chemotherapy.
In the case of COVID, Bell said, experts believe that the symptoms are caused by “an inflammatory reaction to the virus” that can affect the brain as well as the rest of the body. And it makes sense that some people experience multiple neurological symptoms simultaneously or in clusters, Bell said, because “there’s only so much real estate in the brain, and there’s a lot of overlap” in regions responsible for different brain functions.
“If you have inflammation disturbances,” she said, “you can very well have cognitive effects and things like emotional effects. It’s really hard to have one neurological problem without having multiple.”
Dr. Allison P. Navis, a neuro-infectious disease specialist at Mount Sinai Health System in New York City who was not involved in the study, said that about 75% of her 200 post-COVID patients were experiencing issues like “depression, anxiety, irritability or some mood symptoms.”
Participants in the study were overwhelmingly white, and 70% were women. Navis and others said that the lack of diversity quite likely reflected the demographics of people able to seek care relatively early in the pandemic rather than the full spectrum of people affected by post-COVID neurological symptoms.
“Especially in New York City, the majority of patients who got sick with COVID are people of color and Medicaid patients, and that’s absolutely not the patients one sees at the post-COVID center,” Navis said. “The majority of patients are white, often they have private insurance, and I think we have to figure out a little bit more what’s going on there with those disparities — if it’s purely just a lack of access or are symptoms being dismissed in people of color or if it’s something else.”
In the Northwestern study, Koralnik said that because coronavirus testing was difficult to obtain early in the pandemic, only half of the participants had tested positive for the coronavirus, but all had the initial physical symptoms of COVID-19. The study found very little difference between those who had tested positive and those who had not. Koralnik said that those who tested negative tended to contact the clinic about a month later in the course of the disease than those who tested positive, possibly because some had spent weeks being evaluated or trying to have their problems addressed by other doctors.
Khan was among the participants who had a negative test for the virus, but she said she later tested positive for coronavirus antibodies, proof that she had been infected.
Another study participant, Eddie Palacios, 50, a commercial real estate broker who lives in Naperville, a Chicago suburb, tested positive for the coronavirus in the fall, experiencing only a headache and loss of taste and smell. But “a month later, things changed,” he said.
“I was cleaning my gutters and I forgot where I was, I forgot what I was doing on the roof,” Palacios said. When he remembered, he added, the idea of doing “something as simple as climbing on a ladder all of a sudden became a mountain.”
In his job, “my clients would tell me things like a passcode or an address and I couldn’t remember it,” he said.
At Palacios’s first appointment with the Northwestern clinic, “I did the cognitive tests, and I failed them all,” he said. On a return visit, he did another battery of tests, he said, “and I didn’t do so hot on that, either.”
Palacios was referred for cognitive rehab at a long-established program in Chicago that helps give patients strategies to manage and improve memory, organizational and cognitive difficulties. But he did not go, he said, because “I completely forgot.” He plans to go now.
In the Northwestern study, 43% of the patients had depression before having COVID-19; 16% had previous autoimmune diseases, the same percentage of patients who had previous lung disease or had struggled with insomnia.
Experts cautioned that because the study was relatively small, these preexisting conditions might or might not be representative of all long-term patients.
“We are all seeing very small pieces of the elephant in terms of the long COVID group,” Bell said. “Some of us are seeing tail; some of us are seeing trunk.”
Along with neurological symptoms, 85% of the patients were experiencing fatigue, and nearly half had shortness of breath. Some also had chest pain, gastrointestinal symptoms, variable heart rate or blood pressure. Nearly half of the participants were experiencing depression or anxiety.
Khan said that she experienced “heart palpitations if I just got up to open the curtains.” Her cardiologist said she was the fifth previously healthy young person to walk into his office that week. In the beginning, her fatigue was so severe that walking two or three laps around her 600-square-foot apartment would exhaust her for the rest of the day. In addition, she said that she had “really intense mood fluctuations that don’t feel like they’re mine.”
“Waking up every day in this body, sometimes hope feels a little dangerous,” said Khan, who will soon start the cognitive rehab program. “I have to wonder: Am I going to recover, or am I going to just figure out how to live with my new brain?”
This article originally appeared in The New York Times.
© 2021 The New York Times Compan

 

[Hypocrite-The]

1 in 3 COVID-19 survivors suffer mental, neurological problems: Study
A woman receives a Pfizer-BioNTech COVID-19 vaccine jab, at Guy's Hospital, in London, Britain on Dec 8, 2020. (Photo: Victoria Jones/Pool via Reuters)
07 Apr 2021 07:11AM
(Updated: 07 Apr 2021 07:20AM)
Bookmark
PARIS: One in three people who recover from COVID-19 suffer from a neurological or psychiatric diagnosis six months on, according to the largest study so far published on the mental toll that long-COVID-19 takes on survivors.
Authors said the research, printed on Wednesday (Apr 7) in The Lancet Psychiatry journal, proved that COVID-19 patients were significantly more likely to develop brain conditions than those suffering from other respiratory tract infections.
Studying the health records of more than 230,000 patients who had recovered from COVID-19, they found that 34 per cent were diagnosed with a neurological or psychiatric condition within six months.
The most common conditions were anxiety (17 per cent of patients) and mood disorders (14 per cent).
For 13 per cent of patients, the disorders were their first diagnosis of a mental health issue.
Incidence of neurological disorders such as brain haemorrhage (0.6 per cent), stroke (2.1 per cent) and dementia (0.7 per cent) was lower overall than for psychiatric disorders, but the risk for brain disorders was generally higher in patients who had severe COVID-19.
The authors also examined data from more than 100,000 patients diagnosed with influenza and more than 236,000 diagnosed with any respiratory tract infection.
They found there was overall a 44 per cent greater risk of neurological and mental health diagnoses after COVID-19 than after a flu, and a 16 per cent higher risk than with respiratory tract infections.
Paul Harrison, lead author from the University of Oxford, said that while the individual risk of neurological and psychiatric orders from COVID-19 was small, the overall effect across the global population could prove to be "substantial".
"Many of these conditions are chronic," he said.
"As a result, health care systems need to be resourced to deal with the anticipated need, both within primary and secondary care services."
READ: WHO says AstraZeneca COVID-19 vaccine benefits outweigh risks; assessing latest data
"SEVERE IMPACT"
Patients hospitalised with severe COVID-19 were at great risk of developing long-term conditions, according to the analysis.
For example, 46 per cent of patients who needed intensive care were diagnosed with neurological or psychiatric conditions within six months of recovery.
The data showed 2.7 per cent of people needing intensive care suffered a subsequent brain haemorrhage, compared to 0.3 per cent of people who were not hospitalised.
And nearly 7 per cent of those needing intensive care suffered a stroke, compared with 1.3 per cent of patients who did not
Writing in a linked comment article, Jonathan Rogers from University College London, said further research was needed on the long-term neurological and psychiatric outcomes among COVID-19 patients.
"Sadly, many of the disorders identified in this study tend to be chronic or recurrent, so we can anticipate that the impact of COVID-19 could be with us for many years," said Rogers, who was not involved in the study.
"It is clear from this study that the impact COVID-19 is having on individuals mental health can be severe," said Lea Milligan, CEO of the MQ Mental Health research group.
"This is contributing to the already rising levels of mental illness and requires further, urgent research."

 

[Hypocrite-The]

People who have recovered from COVID-19 may be at risk of developing blood clots: Singapore study
ntu covid 19 blood clot study
Research Assistant Florence Chioh and Assistant Professor Christine Cheung analysing the data from 30 blood samples of recovered COVID-19 patients. (Photo: NTU Singapore)
Bookmark
SINGAPORE: People who have recovered from COVID-19, especially those with pre-existing cardiovascular conditions, may be at risk of developing blood clots due to a lingering and overactive immune response, a Singapore study has found.

The study, led by Nanyang Technological University (NTU) scientists, investigated the possible link between COVID-19 and an increased risk of blood clot formation, shedding light on the medium- and long-term consequences of infection, or “long-haul COVID”, NTU said in a news release on Tuesday (Apr 13).

The team collected and analysed blood samples from 30 COVID-19 patients about a month after they had recovered from the infection and were discharged from hospital.

In findings published in the peer-reviewed scientific journal eLife in March, researchers found signs of blood vessel damage in all 30 patients, possibly from a lingering immune response, which may trigger the formation of blood clots.

"The findings may help to explain why some people who have recovered from COVID-19 exhibit symptoms of blood clotting complications after their initial recovery," said NTU.

"In some cases, they are at increased risk of heart attack, stroke or organ failure when blood clots block major arteries to vital organs."

READ: Doctors in Singapore advised to look out for blood, heart problems in COVID-19 patients
NTU's Assistant Professor Christine Cheung, who led the study, said: "With more people recovering from COVID-19, we started hearing from clinicians about patients returning with blood clotting issues after they had been discharged and cleared of the virus.

“This makes a strong case for the close monitoring of recovered COVID-19 patients, especially those with pre-existing cardiovascular conditions like hypertension and diabetes who have weakened blood vessels.”

OVERACTIVE IMMUNE SYSTEM AFTER RECOVERY

The scientists found that recovered COVID-19 patients had twice the normal number of circulating endothelial cells (CECs) that had been shed from damaged blood vessel walls.

The elevated levels of CECs indicate that blood vessel injury is still apparent after recovering from viral infection.

The recovered COVID-19 patients continued to produce high levels of cytokines – proteins produced by immune cells that activate the immune response against pathogens – even in the absence of the virus.

"Unusually high numbers of immune cells, known as T cells, that attack and destroy viruses were also present in the blood of recovered COVID-19 patients," said NTU.

The presence of both cytokines and higher levels of immune cells suggest that the immune systems of recovered COVID-19 patients remained activated even after the coronavirus was gone from the patient.

These "persistently activated immune responses" may attack the blood vessels of recovered COVID-19 patients, causing even more damage and increasing the risk of blood clot formation further, the researchers said.

READ: COVID-19: Why 3 positive cases who died from heart issues were not added to Singapore’s official death toll
Explaining how blood vessel damage may cause the formation of blood clots, NTU research assistant Florence Chioh said: “While COVID-19 is mainly a respiratory infection, the virus may also attack the linings of blood vessels, causing inflammation and damage.

"Leakage from these damaged vessels triggers the formation of blood clots that may result in the sort of complications seen in the patients during hospitalisation.”

These findings could inform guidelines for post-hospitalisation care of COVID-19 patients who might be susceptible to "long-haul COVID" symptoms, said the research team. For hospitalised patients, the World Health Organization recommends the use of low dose anticoagulants to prevent blood clots from forming in blood vessels.

“Those with cardiovascular conditions need to be more cautious since their underlying conditions already weaken their vascular systems," said Asst Prof Cheung.

"It’s a double blow with COVID-19. As we gain greater understanding of complications COVID ‘long-haulers’ face, there is hope to encourage vaccine take-up rate to protect oneself from both the virus and its long-term complications.”

The team comprised researchers from NTU, the Agency for Science, Technology and Research’s (A*STAR) Singapore Immunology Network, and the National Centre of Infectious Diseases.

One of the co-authors Professor Lisa Ng, executive director of A*STAR Infectious Diseases Labs, said: "We found that COVID-19 patients with vascular complications have a higher frequency of T cells, which may in turn attack the blood vessels. Preventive therapy may be needed for these patients.”

The team is now investigating the longer-term effects of COVID-19 in patients who have recovered from the infection for at least six months or longer, NTU said.

 

[kaninabuchaojibye]

People who have recovered from COVID-19 may be at risk of developing blood clots: Singapore study
ntu covid 19 blood clot study
Research Assistant Florence Chioh and Assistant Professor Christine Cheung analysing the data from 30 blood samples of recovered COVID-19 patients. (Photo: NTU Singapore)
Bookmark
SINGAPORE: People who have recovered from COVID-19, especially those with pre-existing cardiovascular conditions, may be at risk of developing blood clots due to a lingering and overactive immune response, a Singapore study has found.

The study, led by Nanyang Technological University (NTU) scientists, investigated the possible link between COVID-19 and an increased risk of blood clot formation, shedding light on the medium- and long-term consequences of infection, or “long-haul COVID”, NTU said in a news release on Tuesday (Apr 13).

The team collected and analysed blood samples from 30 COVID-19 patients about a month after they had recovered from the infection and were discharged from hospital.

In findings published in the peer-reviewed scientific journal eLife in March, researchers found signs of blood vessel damage in all 30 patients, possibly from a lingering immune response, which may trigger the formation of blood clots.

"The findings may help to explain why some people who have recovered from COVID-19 exhibit symptoms of blood clotting complications after their initial recovery," said NTU.

"In some cases, they are at increased risk of heart attack, stroke or organ failure when blood clots block major arteries to vital organs."

READ: Doctors in Singapore advised to look out for blood, heart problems in COVID-19 patients
NTU's Assistant Professor Christine Cheung, who led the study, said: "With more people recovering from COVID-19, we started hearing from clinicians about patients returning with blood clotting issues after they had been discharged and cleared of the virus.

“This makes a strong case for the close monitoring of recovered COVID-19 patients, especially those with pre-existing cardiovascular conditions like hypertension and diabetes who have weakened blood vessels.”

OVERACTIVE IMMUNE SYSTEM AFTER RECOVERY

The scientists found that recovered COVID-19 patients had twice the normal number of circulating endothelial cells (CECs) that had been shed from damaged blood vessel walls.

The elevated levels of CECs indicate that blood vessel injury is still apparent after recovering from viral infection.

The recovered COVID-19 patients continued to produce high levels of cytokines – proteins produced by immune cells that activate the immune response against pathogens – even in the absence of the virus.

"Unusually high numbers of immune cells, known as T cells, that attack and destroy viruses were also present in the blood of recovered COVID-19 patients," said NTU.

The presence of both cytokines and higher levels of immune cells suggest that the immune systems of recovered COVID-19 patients remained activated even after the coronavirus was gone from the patient.

These "persistently activated immune responses" may attack the blood vessels of recovered COVID-19 patients, causing even more damage and increasing the risk of blood clot formation further, the researchers said.

READ: COVID-19: Why 3 positive cases who died from heart issues were not added to Singapore’s official death toll
Explaining how blood vessel damage may cause the formation of blood clots, NTU research assistant Florence Chioh said: “While COVID-19 is mainly a respiratory infection, the virus may also attack the linings of blood vessels, causing inflammation and damage.

"Leakage from these damaged vessels triggers the formation of blood clots that may result in the sort of complications seen in the patients during hospitalisation.”

These findings could inform guidelines for post-hospitalisation care of COVID-19 patients who might be susceptible to "long-haul COVID" symptoms, said the research team. For hospitalised patients, the World Health Organization recommends the use of low dose anticoagulants to prevent blood clots from forming in blood vessels.

“Those with cardiovascular conditions need to be more cautious since their underlying conditions already weaken their vascular systems," said Asst Prof Cheung.

"It’s a double blow with COVID-19. As we gain greater understanding of complications COVID ‘long-haulers’ face, there is hope to encourage vaccine take-up rate to protect oneself from both the virus and its long-term complications.”

The team comprised researchers from NTU, the Agency for Science, Technology and Research’s (A*STAR) Singapore Immunology Network, and the National Centre of Infectious Diseases.

One of the co-authors Professor Lisa Ng, executive director of A*STAR Infectious Diseases Labs, said: "We found that COVID-19 patients with vascular complications have a higher frequency of T cells, which may in turn attack the blood vessels. Preventive therapy may be needed for these patients.”

The team is now investigating the longer-term effects of COVID-19 in patients who have recovered from the infection for at least six months or longer, NTU said.

no issue
just take cardiprin
even if no covid, shd take daily after 55 yo

 

[Hypocrite-The]

no issue
just take cardiprin
even if no covid, shd take daily after 55 yo

The blood clots by the vaccine is in the brain,,,does this medication help?

 

[kaninabuchaojibye]

The blood clots by the vaccine is in the brain,,,does this medication help?

yes it does
just walk into any guardian
u can purchase from the shelves
no prescription needed
cheap and effective against strokes and heart attAck
take daily
make it a habit
it will save u
u still can get stroke or heart attAck even without covid

 

[kaninabuchaojibye]

The blood clots by the vaccine is in the brain,,,does this medication help?

https://www.health.harvard.edu/healthbeat/should-everyone-take-an-aspirin-a-day

Should everyone take an aspirin a day?
Published: March, 2010
If you are having a heart attack, chewing a full-strength aspirin tablet can be a lifesaving move. If you have heart disease, have had a heart attack or stroke, or are at very high risk for having one, taking a low-dose aspirin every day is part of a proven strategy for preventing one of these life-changers. Aspirin makes blood platelets less "sticky." This limits the formation of clots in the bloodstream, which can trigger heart attacks and strokes. But what if you are relatively healthy? Will taking aspirin help you keep heart attack, stroke, and other forms of cardiovascular disease at bay?
If taking aspirin were without side-effects and completely risk free, it might make sense for everyone with heart disease, or just worried about it, to take it. But aspirin does have risks. Reducing blood's clotting potential can lead to hemorrhagic stroke (bleeding inside the brain). In the stomach, aspirin can cause everything from a feeling of mild heartburn to bleeding ulcers. Severe gastrointestinal bleeding can be deadly.
The benefit-risk balance
It's the balance of benefits and risks that guides who should take aspirin for primary prevention — preventing heart attack, stroke, or another manifestation of cardiovascular disease in seemingly healthy people.
Researchers from six large primary prevention trials of aspirin pooled their data and analyzed them as if they were from a single large trial. It's a legitimate technique called meta-analysis. In this relatively healthy group of 95,000 volunteers, the reduction in heart attacks and strokes in people taking aspirin was almost counterbalanced by major bleeding in the gastrointestinal system and the brain. The researchers concluded that for individuals without previously diagnosed cardiovascular disease, "aspirin is of uncertain net value."
Another meta-analysis showed only a modest overall benefit, if any, for aspirin among people with diabetes but no cardiovascular disease, and it had little impact on heart attack or stroke. When the researchers analyzed the data by sex, aspirin reduced the risk of heart attack in men but not women.
The British journal Drug and Therapeutic Bulletin also weighed in on the topic in November 2009. After reviewing and analyzing information from relevant primary prevention studies, the journal's editors concluded that the benefits and harms "may be more finely balanced than previously thought," and aspirin should not be recommended as an across-the-board option to help healthy people prevent heart attack and stroke.
Finding the tipping point
Don't take aspirin just because you've heard it can help prevent a heart attack or stroke. It can, but it can also do some damage. There's no exact tipping point at which it makes sense to start taking an aspirin a day. If you are healthy, haven't been diagnosed with heart disease or other cardiovascular disease, and don't have risk factors for them, aspirin probably isn't for you. You'll reap little benefit while exposing yourself to side effects you'd rather stay away from. The less healthy your heart and arteries, the more likely the advantages of taking aspirin will outweigh any risks.
It isn't the easiest decision to make. If you are in the gray zone, talking with your doctor could make it more black and white.

 

[Hypocrite-The]

https://www.bitchute.com/video/UlBTwb8tvdae/


MRNA C19 VACCINE RISKS FAR OUTWEIGH THE BENEFIT

DR. BRIAN TYSON, MD from All Valley Urgent Care in El Centro, CA explains early treatment HYDROXYCHLOROQUINE mean Covid-19 Experimental mRNA Vaccine are not necessary.

There is no reason whatsoever to play Russian Roulette with your life when there is a 99.97% percent survival rate (without any medical intervention), and several early treatment options are available.

The mRNA Experimental Therapy risk ABSOLUTELY DOES NOT outweigh the reward. Other highly effective protocols that are very inexpensive are Ivermectin and Azithromycin.

Furthermore, Vitamin D and Vitamin C are highly effective in building up your immune system against all types of viruses, so that you don't get symptoms/sick in the first place.

One America News Network
March 17

 

[laksaboy]

Vaccines won't work. Here's why:

View attachment 108767

 

[Hypocrite-The]

Experts warn coronavirus may cause 'wave' of neurological conditions including Parkinson's disease
By national medical reporter Sophie Scott and the Specialist Reporting Team's Lucy Kent and Penny Timms
Posted WedWednesday 23 SepSeptember 2020 at 1:26am, updated FriFriday 25 SepSeptember 2020 at 7:43am

Brain imaging at the Florey Institute shows changes in patients with Parkinson's disease compared to healthy volunteers.(
ABC News: Patrick Stone
)
Share

COVID-19 can cause worrying neurological symptoms like a loss of smell and taste, but Australian scientists are warning the damage the virus causes to the brain may also lead to more serious conditions such as Parkinson's disease.
Key points:

• Researchers are warning some well-known COVID-19 symptoms indicate there may be long-term neurological impacts of the disease
• There is a fear a "silent wave" of Parkinson's disease will follow the COVID-19 pandemic, as it did after the Spanish flu in the early 20th century
• Medical experts have designed a smell test to improve the early detection of Parkinson's disease and treatment options

It has happened before.
Five years after the Spanish flu pandemic in the 1910s, there was up to a three-fold increase in the incidence of Parkinson's disease.
Kevin Barnham from the Florey Institute of Neuroscience and Mental Health said he believed a similar "silent wave" of neurological illness would follow this pandemic.
"Parkinson's disease is a complex illness, but one of the causes is inflammation, and the virus helps to drive that inflammation," he said.
"Once the inflammation gets into the brain, it starts a cascade of events which can ultimately lead to Parkinson's disease.

"Let me put it this way, I don't want to catch this virus. I am doing everything I can to avoid catching it."

Researchers outlined their concerns in a study published in the Journal of Parkinson's Disease.
The process is known as the "two-hit hypothesis".
Keep up to date with the latest news on the pandemic with the ABC's coronavirus page
The brain gets inflamed from something like a virus, then something else comes along later causing more damage and eventually Parkinson's disease develops.
"Evidence is already suggesting the triggers for Parkinson's disease are there with this virus," Professor Barnham said.
Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.
WATCH
Duration: 21 seconds21s

How the COVID-19 virus may be linked to Parkinson's Disease
Medical experts said it was too early to know how many people who had COVID-19 would go on to develop the disease.
"I believe the risk is real," Professor Barnham said.
"We can't put a number on it, but with 30 million people worldwide affected by this virus, even a small shift in the risk of getting Parkinson's would lead to many more people being diagnosed.
"We know COVID-19 has short-term effects, but we are realising more about the potential long-term effects."
Do you know more about this story? Email [email protected]
Head of the cognition ageing laboratory at the University of Adelaide, Lyndsey Collins-Praino, said it was not a certainty every person who had COVID-19 would develop Parkinson's disease.
She said researchers needed a better understanding of just how people with COVID-19 were likely to develop the disease in the future.
"We need to know what that may look like and how symptoms may change and evolve over time," Dr Collins-Praino said.
"We need to understand not just how to treat the virus itself, but to understand what challenges survivors may face, given how many people may find themselves in that camp."
Smell-test screening to pick up early signs of disease
In people with Parkinson's disease, problems such as a loss of smell can show up 10 years before they have any physical symptoms.
Researchers from the Florey Institute are working on a smell-test screening tool that could be rolled out to everyone over the age of 50.
It would measure your ability to smell properly and test the function of other parts of the brain, the results of which may signal early indications of Parkinson's disease.

The Florey Institute is working on a test that would measure any loss in someone's sense of smell.(
ABC News: Patrick Stone
)
Dr Collins-Praino said early diagnosis could lead to early intervention and stop brain cells from dying off.
"The earlier we can detect [the damage], the better our chances of really effective and meaningful therapeutics for individuals," she said.
Six million people worldwide have Parkinson's disease and the figure is expected to double in the next 20 years.
"Add to that the silent wave from COVID, and those numbers will explode and there will be serious societal and economic consequences from that," Professor Barnham said.
Florey Institute scientist and co-author of the paper, Leah Beauchamp, said there was an opportunity to get ready.
"We weren't prepared the last time — more than 100 years ago. We have the tools and we can get ahead of this now," she said.

"The real question is: Are we prepared to take action now to avoid history repeating itself?"

Leah Beauchamp and Kevin Barnham are co-authors of the paper published in the Journal of Parkinson's Disease.(
ABC News: Patrick Stone
)Parkinson's 'wasn't anything we had considered'
Getting an earlier diagnosis would have helped Melbourne woman Sheenagh Bottrell.
One of the first signs something was amiss was when her friend noticed she was limping while they were out on their regular walks.
"I had already had problems with my shoulder, but I really didn't worry about it very much," Ms Bottrell said.
"But my friend was constantly at me to go and see the doctor."
Read our full coverage of the coronavirus pandemic
After seeing a neurologist, Ms Bottrell, 47, was diagnosed with Parkinson's disease in 2011.
"It was a shock. It wasn't anything we had considered," she said.

Sheenagh Bottrell, 47, says she has tried "to get on with life" after her Parkinson's disease diagnosis.(
ABC News: Patrick Stone
)
Ms Bottrell said if she had been diagnosed earlier, she might have done things differently.
"I am fortunate that I have mild symptoms, but for people who have tremors, earlier detection and getting onto good treatment early would be much better," she said.
Doctors advised Ms Bottrell not to let the illness take over her life and her thinking.
"I have tried to get on with life and not let it get in the way," she said.
The Florey Institute has applied to the Federal Government's Medical Research Future Fund for a grant to move to the next phase of testing the smell screening tool.

 

[Hypocrite-The]

Scientists find ‘blood abnormalities’ in recovered patients
Prof Nicholson said more than 160 million people worldwide had suffered from a less severe form of COVID-19.

“We are undertaking follow up studies to assess recovery and what we’ve found is cause for concern,” he said. “This is an immensely dangerous disease that is not only costing lives today, but as we’re discovering now, may have serious health consequences for some patients long into the future, even in relatively mild original cases.”

However, Prof Nicholson said some biochemical patterns related to heart disease and atherosclerosis risk do appear to go back to normal in some patients. “So it is not all bad news,” he said.

The professor said the most recent study provided a framework to accurately identify those suffering from long-term effects and what those effects are, which is helpful in developing personalised long-term treatments they may need.

“Now that we have developed an objective metabolic framework for measuring systemic recovery in COVID-19 patients, we can use this to definitively track whether people are in fact fully recovering from the disease,” he said.

Further studies with more people are needed to confirm the biomarkers needed for long-term monitoring.

It is not known whether “Long Covid”, also known as Post-Acute COVID-19 Syndrome (PACS), is an extension of the disease or marks the start of separate chronic disease driven by the body’s enhanced immune response to the virus.

“There are now over 140 million so-called ‘recovered’ people around the world, so it is possible that long-term effects will be seen in tens of millions of people with significantly increased healthcare economic burdens as well as the individual medical problems,” Prof Nicholson said.

The findings from the study — a collaboration with the Covid Research Response Trial led by the University of Western Australia, the ANPC, Spinnaker Health Research Foundation and South Metropolitan Health Service — have been published in a peer-reviewed paper in the Journal of Proteome Research (American Chemical Society).

University of Western Australia endocrinologist Professor Bu Yeap said the research marks an important milestone in delivering better care to those affected.

“The results show that there are persisting metabolic and inflammatory changes in patients after acute COVID-19 infection, which relate to some Long Covid symptoms,” Prof Yeap said.

“This is an important step towards better understanding the long-term health impacts of COVID-19, which would help us provide better care for those affected.”

 

[eatshitndie]

because if you look deep inside the virus with an electron microscope you’ll find “made in china” label.

 

[laksaboy]

because if you look deep inside the virus with an electron microscope you’ll find “made in china” label.

https://twitter.com/LawrenceSellin

The Chicoms were also funded/assisted by some nasty people in the USA and some western countries. However, the bioweapons program was solely on the Chinese military. No use denying it.

 

[Hypocrite-The]

WHO 'deeply concerned' by long COVID-19
WHO 'deeply concerned' by long COVID-19
Long COVID-19 remains one of the most mysterious aspects of the pandemic of the coronavirus pandemic.
05 Aug 2021 04:04AM (Updated: 05 Aug 2021 04:11AM)
GENEVA: With nearly 200 million people known to have had COVID-19, the WHO said on Wednesday (Aug 4) it was deeply concerned by the unknown numbers who may still be suffering with long COVID-19.

The World Health Organization urged people struggling with the after-effects of the virus - despite having recovered from the acute phase - to seek medical help.

Advertisement
Long COVID-19 remains one of the most mysterious aspects of the pandemic.

"This post-COVID syndrome, or long COVID, is something that WHO is deeply concerned about," Maria Van Kerkhove, the UN health agency's COVID-19 technical lead, told a press conference.

The WHO was "making sure that we have recognition of this, because this is real".

She said of those infected with SARS-CoV-2 - the virus which causes COVID-19 disease - "many are suffering from long term effects".

"We don't know for how long these effects last and we're even working on a case definition to better understand and describe what this post-COVID syndrome is," said Van Kerkhove.

Advertisement
She said the WHO was working to have better rehabilitation programmes for long COVID-19 sufferers plus broader research to gain a better understanding of what the syndrome is and how it can be managed.

Britain backs slew of 'long COVID-19' research studies
MORE THAN 200 SYMPTOMS

The WHO has held a series of seminars this year aimed at expanding understanding of post-COVID-19 conditions, hearing not only from scientists and doctors but also directly from sufferers themselves.

Little is known about why some people, after coming through the acute phase, struggle to recover and suffer ongoing symptoms including shortness of breath, extreme fatigue and brain fog as well as cardiac and neurological disorders.

Janet Diaz, the clinical care lead in the WHO's emergencies programme who leads the organisation's long COVID-19 efforts, said there had been more than 200 reported symptoms.

Advertisement
They include chest pain, tingling and rashes, she told a WHO live social media session on Tuesday.

Diaz said some patients had symptoms that dragged on from the acute phase; others got better and then relapsed, with conditions that could come and go; while others had symptoms that only appeared after recovering from the acute phase.

Studies can only go back as far as the first patients to recover from COVID-19, which first emerged in China in December 2019.

NCID studying cases of 'long COVID'; condition shows disease not 'a common seasonal flu'
Diaz said some people seemed to have post-COVID-19 conditions for three months, and others up to six months.

"We are concerned there may be a small proportion that go on to nine months - and to longer than that," said Diaz.

Advertisement
The US expert said it was not yet fully understood what caused the post-viral symptoms, with various hypotheses including neurological problems, the immune response to the infection, and the virus persisting in some organs.

Van Kerkhove said: "We advise anyone who is suffering from the long-term effects to seek help."

 

[Hypocrite-The]

Family’s tragic battle months after Covid
A Sydney couple, who caught Covid early last year when the virus was just hitting Australia, are now facing a massive health battle 18 months later.

Natalie Wolfe
Vaccine Side Effects: What to Expect After Your Covid-19 Shot
NOW PLAYING
Resume
Mid-Session 30 Aug 2021: Surging mining stocks offset widespread losses

3:04


Maintaining peace in the region 'doesn't come for free'

3:15


US-Australia commerce relationship a ‘very busy two-way street’

5:59


As more U.S. adults get their Covid-19 vaccines, a variety of…
A Sydney man is still grappling with the ongoing effects of coronavirus, more than 18 months after he and his wife caught the disease, with fears he could soon be put on a heart transplant list due to the virus.

Amanda and Rob Hodges were some of the first people in Australia to catch coronavirus when Rob returned from a work trip in New York on March 13 last year.

By the next day he had started coughing and on the 18th, tested positive to Covid.

Amanda, who spoke to news.com.au about her husband’s health battle, tested positive on March 21.

Mrs Hodges said the couple were sick for two weeks, with both of them suffering aches and joint pain and coughing.

However, the couple, who were both fit and healthy at the time of their diagnosis, appeared to recover well after a fortnight.

Amanda said the couple even put themselves through a fitness program “just to show ourselves we were OK” after hearing of how much Covid could impact their health.

Amanda and Rob Hodges. Picture: Instagram
Amanda and Rob Hodges. Picture: Instagram

Everything seemed fine for the Hodges family – with 38-year-old Rob even taking part in a 1300km charity ride for kids cancer in October last year.

However things changed in November, when Rob was in the family’s garage training on his bike.

“He was doing a ride in the garage on the wind trainer and felt dizzy, he told me he thought he was going to pass out,” Amanda said.

“But it was a really hot day so we ignored it, we thought it must’ve been that.”

Half an hour later, Amanda was serving dinner for the family when Rob called out to her from the loungeroom.

He was lying down and his heart was beating rapidly, at 210 beats per minute.

An ambulance was called, with paramedics telling Rob he didn’t need to go the hospital, but advising him to see a GP in the next 24 hours.

Amanda said her husband’s health issues came at a peculiar time, with the couple receiving texts from Westmead Hospital encouraging them to come for a check-up six months after their Covid diagnosis.

Rob’s text message had come a few days before he collapsed but, due to how fit and healthy he was feeling, didn’t think it was necessary.

Amanda went for her six-month Covid check-up at Westmead Hospital two days after her husband collapsed, making a casual comment about the situation to doctors.

“I said, ‘I don’t know if this is important but my husband collapsed a few days ago’ ... the doctor looked at me wide-eyed and told him to come in straight away,” she said.

After numerous tests and a number of cardiology appointments, Rob was diagnosed with dilated cardiomyopathy, a disease that stops the heart pumping enough blood around the body.

Cardiologists recommended Rob immediately be fitted with a defibrillator, to shock his heart if it was beating irregularly or stopped beating completely.

The doctors studying Rob believe the Covid infection worked its way through his heart and “caused scarring, disrupting the way his heart is supposed to work”, Amanda said.

“The doctors said the scarring looks exactly like what happens when virus travels through your heart.”

The cardiologists at Westmead Hospital, in Sydney’s west, have asked to write a medical paper on Rob, to better study his condition.

“He’s the first case of this for them but they had seen enough cases overseas to tell him to see a specialist straight away.

“We haven’t had enough cases here and of course here it’s a minimal chance, but when you hear that there’s a small percentage of risk – well that number is people and it’s hard for us to ignore.”

Rob was fitted with the defibrillator on December 16 and was working his way back to exercise, slowly working out on his bike, when on January 5 he had another episode.

“I’ll never forget it. He yelled my name and was standing up next to the bike telling me he had been shocked by the Dfib,” Amanda said.

As Rob lay down to try and calm his body, the Dfib shocked him again.

Paramedics were called, telling Rob the Dfib likely saved his life.

Since Rob’s first heart episode in November, the family have since been battling through the mental and physical toll of it all.

“(Rob) is dealing with a lot of fear and loss, he’d just started doing a lot of cardiac rehab to get back on his bike when he was shocked again.”

Rob went in for surgery last week, with doctors delivering more harrowing news.

After going off his anti-arrhythmia drugs before surgery, to allow doctors to try and find exactly where the arrhythmia in his heart was coming from, doctors said they’d hit a wall.

“The doctor told him, ‘I couldn’t see where your arrhythmia is coming from which likely means your heart muscle is not working and you’re going into cardiac failure’,” Amanda said.


Rob is now booked in to see a transplant specialist next month, with the doctor likely recommending the 38-year-old go on the list for a new heart.

The family had a meeting with the transplant specialist earlier this year, who expressed his shock at Rob’s diagnosis.

“The doctor said ‘we don’t see 38-year-old guys with this’,” Amanda said.

“The transplant doctor said there was no reason to put him on the list because he functions quite well and he’s fit, he doesn’t seem like he’s going into heart failure.”

The couple have asked if the medication and the Dfib will maintain Rob’s heart for long enough but doctors said he’s likely facing heart failure in the next 18 months.

The couple are also grappling with telling their two sons – aged seven and nine.

“It’s all a bit full on. I’m a performance coach so I’m normally very positive, but this sucks,” Amanda said.

“We haven’t told the kids (about the transplant) yet ... we‘re coming to the end of school holidays so we’re just trying to create happy memories before we go back to doom and gloom.”

With the average wait time for a new heart in Australia being around six months, Amanda said the family was just “staying on our toes and being ready for when it comes”.

Read related topics:

 

[Hypocrite-The]

https://news.sky.com/story/doctor-w...ns-plan-to-end-all-coronavirus-rules-12543375

Oh no...better off dead...

Doctor with long COVID who suffered violent shakes and hallucinations attacks Boris Johnson's plan to 'live with virus'​

With the prime minister set to unveil his "living with COVID" plan on Monday, Dr Kelly Fearnley branded it a "strategy of denial" as she battles the ongoing effects of coronavirus 15 months after contracting the virus.

David Mercer
Home affairs reporter @DavidMercerSky
Sunday 20 February 2022 19:08, UK

0:44





Play Video - This is the impact of long COVID

This is the impact of long COVID

• https://www.facebook.com/sharer/sha...cks Boris Johnson's plan to 'live with virus'
• https://twitter.com/intent/tweet?te...ns-plan-to-end-all-coronavirus-rules-12543375
• https://www.sammyboy.com/whatsapp:/...ns-plan-to-end-all-coronavirus-rules-12543375

Why you can trust Sky News
A doctor who has suffered violent shakes and hallucinations during her ongoing 15-month battle with long COVID has criticised the government's plan to "live with the virus".
Dr Kelly Fearnley told Sky News she contemplated ending her own life due to the debilitating long-term effects of coronavirus, which she caught while working on a COVID ward in November 2020.


The 35-year-old from Leeds, who was previously fit and healthy, initially had flu-like symptoms before she suffered shortness of breath and painful rashes over her body, as well as swelling around her eye.

Imager Fearnley suffered swelling on her eyelid after contracting COVID
More than a year later, she is still unable to return to work due to the effects of long COVID, which have included violent shakes lasting up to 14 hours at a time, hallucinations, night terrors, severe pins and needles in her arms and legs, and a resting heart rate of 140 beats per minute.
With Prime Minister Boris Johnson set to unveil his "living with COVID" plan on Monday, Dr Fearnley branded it a "strategy of denial, driven by the need to cut costs" and she felt "angry and let down".
Downing Street has announced that, by the end of next week, people in England will no longer have to self-isolate after testing positive. Reports also suggest free lateral flow tests will be scrapped and the £500 self-isolation payment for people on low incomes will come to an end.
The PM has previously announced plans to abolish all remaining COVID restrictions in England this month.

Imager Fearnley was working on a COVID ward when she contracted the virus
Dr Fearnley told Sky News that scrapping the measures was "both dangerous and irresponsible" and it was evidence of the government's "complete disregard for human life".
She said: "The health of the economy takes precedence over the health of nation. And yet their strategy to 'live with COVID' not only fails to follow the science, but it also fails to follow the money.
"The human and economic burden of long COVID alone will dwarf the sums of money they expect to save through their strategy to 'live with COVID'."
She added: "It neither makes moral nor economic sense. The lunatics really are in charge of the asylum.
"I expect we will see the long-term health impacts of this virus for decades to come."

Image:Boris Johnson is set to unveil his 'living With COVID' plan on Monday
'I deteriorated very quickly'
Dr Fearnley contracted COVID while working as a newly qualified doctor at Bradford Royal Infirmary during the UK's second wave of the virus.
After initially suffering mild flu-like symptoms, diarrhoea and vomiting, she developed painful red rashes on her body and swelling around her eye, as well as suffering shortness of breath.
After a four-week absence from work, she returned to the hospital - but just hours into her first shift back, Dr Fearnley became dizzy and breathless and had to go home.

Imager Fearnley suffered painful skin rashes after contracting COVID
It was then that she began developing the crippling effects of long COVID.
"I deteriorated very quickly," she said. "I fell off the edge of a cliff - that's how I would describe it.
"I had a resting heart rate of 140 beats per minute. When I stood up, it was increasing to 180 beats per minute.
"I began having cyclic attacks of pins and needles and violent shaking - as violent as a seizure.
"I would frequently shake for 14 hours through the night. It was exhausting - mental, physical and emotional exertion like no other.
"It affected my ability to sleep. I remember I didn't sleep for three days."
Hallucinations and 'sense of impending doom'
Dr Fearnley said she began experiencing "auditory hallucinations" in her home which included a man shouting at her in the kitchen, a train station tannoy announcement, and a dog barking next to her.
She went to a hospital A&E department but doctors believed she was suffering from anxiety and she was sent home, where she was hit by further symptoms.
"I experienced neurological sleep apnea - that's when you stop breathing at night," she added.
"My body would wake me from sleep, or the edge of sleep, and I would realise I wasn't breathing.
"I experienced a sense of impending doom at that time. I can only describe this as a physical, emotional sensation in the chest.
"People often experience a sense of impending doom before they're about to die.
"I was very much on the ropes."

Imager Fearnley struggled with pins and needles in her arms and legs
Vivid night terrors 'revolved around death'
Dr Fearnley said her symptoms appeared to be easing by the middle of January 2021 and she believed she was "over the worse" but she was "absolutely wrong".
Over the next three months, up to seven nights a week, she experienced more hallucinations, she said.
"I would hear a muffled TV, a radio, muffled news reports, music - I would hear bands playing, sometimes it was a heavy metal band. That was distressing," Dr Fearnley said.
"I also experienced vivid night terrors... it was like watching a film and it always revolved around death.
"I remember watching these men being executed - they were all lined up and I watched them be executed.
"It was very upsetting."

Long COVID battle left doctor suicidal
Dr Fearnley said the effect of COVID on her brain also disrupted her emotions as she went from being a "normally stoic person" to "emotionally labile".
She said the devastating impact of long COVID left her suicidal and she considered ending her life around April 2021.
"That was a time when my brain felt infected. I was hallucinating every night," she told Sky News.
"I contemplated how I might end my own life.
"You don't have to depressed to be suicidal. One only has to be in a desperate place.
"At that point there was no support really."

1:55





Play Video - Long COVID patients share 'horrendous' experience

Long COVID patients share 'horrendous' experience
Dr Fearnley, who shares a home with her father and brother, said she has since been diagnosed with limbic encephalitis, a disease caused by inflammation of the brain.
She remains housebound as she is left exhausted by any physical or mental activity and continues to suffer hallucinations intermittently.
"I do feel like it's sustained a traumatic brain injury," Dr Fearnley said.
"I was previously fit and well. I trained for a decade to be a doctor. I've worked alongside my studies to fund them for a number of years.
"It's a complete fallacy that you have to have underlying health issues to have a bad outcome."



Play Video - When will COVID-19 be an endemic?

When will COVID-19 be an endemic?
'We feel expendable'
Dr Fearnley, who has had the coronavirus vaccine since contracting COVID, said that while her employer has been supportive about her time off work, she is worried about the future.
She said she is aware of other doctors who have not been able to return to work due to long COVID.
"We caught COVID caring for COVID patients," she said.
"It's not just me - we feel expendable.
"We're being clapped all the way to the benefits office.
"We stepped up when we needed to step up, and now I feel like we're being abandoned in our hour of need."

Follow the Daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker
Commenting on reports that free lateral flow tests will be scrapped, a government spokesperson previously said: "We've previously set out that we'll keep the provision of free testing under review as the government's response to COVID-19 changes.
"No decisions have been made on the provision of free testing. Everyone can continue to get free tests and we are continuing to encourage people to use rapid tests when they need them.
"Testing continues to play an important role in helping people live their day to day lives, keep businesses running and keep young people in school."

 

[Hypocrite-The]